News

When inflammation goes too far

13 March 2025

Clare Bryant takes a closer look at inflammation, and when our defence systems go too far.

Microbiome: ‘Good’ gut bacteria may protect against Salmonella infection

4 March 2025

New research from scientists at the University of Cambridge reveals how ‘good’ gut bacteria help protect against Salmonella, a major cause of food poisoning.

The Poppy team visit Addenbrooke’s Hospital in Cambridge

Carmel McEniery and the POPPY team are highly commended in the 2024 Cambridge Awards for Research Impact and Engagement

20 February 2025

We're delighted to announce that Dr Carmel McEniery, Principal Research Associate at the Department of Medicine, has been Highly Commended together with the POPPY team in the Established Academic Award of the Cambridge Awards 2024 for their exemplary work in raising awareness, fostering collaborations, and enriching research to improve women's health.

Prioritise vaccine boosters for vulnerable immunocompromised patients

13 February 2025

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University of Cambridge has shown.

New study shows how gut microbes affect cancer immunotherapy responses

12 February 2025

Lipopolysaccharide (LPS) produced in gut microbiota could influence how well cancer patients respond to immunotherapy treatments, as shown in a study published this week in Nature Microbiology .

Professor Duncan Richards appointed as Head of Department of Medicine

15 January 2025

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases

15 January 2025

The Cambridge-GSK Translational Immunology Collaboration (CG-TIC) combines University and GSK expertise in the science of the immune system, AI and clinical development with access to patients and their data provided by Cambridge University Hospitals.

10 Cambridge spinouts changing the story of cancer

15 January 2025

University spinouts are supported through their commercialisation journey by the University's innovation arm, Cambridge Enterprise. Meet 10 of our spinouts, all committed to changing the story of cancer.

Cambridge scientists elected as Members of the European Molecular Biology Organisation

15 January 2025

Five Cambridge researchers, including Dr David Adams, Senior Group Leader from the Department of Medicine, join the community of over 2,100 leading life scientists today as the European Molecular Biology Organisation (EMBO) announces its newest Members in its 60 th anniversary year.

When inflammation goes too far

Microbiome: ‘Good’ gut bacteria may protect against Salmonella infection

Carmel McEniery and the POPPY team are highly commended in the 2024 Cambridge Awards for Research Impact and Engagement

Prioritise vaccine boosters for vulnerable immunocompromised patients

New study shows how gut microbes affect cancer immunotherapy responses

Professor Duncan Richards appointed as Head of Department of Medicine

Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases

10 Cambridge spinouts changing the story of cancer

Cambridge scientists elected as Members of the European Molecular Biology Organisation

Our address

How we use information

Connect with us

Study at Cambridge

About the University

Research at Cambridge